Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
04/2014
04/30/2014CN103751194A Methods and compositions for treating disorders
04/30/2014CN103751193A Pharmaceutical composition comprising linagliptin and optional SGLT2 inhibitor and uses thereof
04/30/2014CN103751192A Pharmaceutical composition comprising linagliptin and optional SGLT2 inhibitor and uses thereof
04/30/2014CN103751184A Application of pregnane X receptor antagonist in preparation of lipid regulation and liver protection product
04/30/2014CN103751150A Method for preparing insulin sustained-release capsules from attapulgite
04/30/2014CN103751146A Vitamin E softgel and preparation method thereof
04/30/2014CN103751136A 维生素c片及其制备方法 Vitamin c tablets and its preparation method
04/30/2014CN103751114A Granular material containing water-insoluble inorganic phosphate binders
04/30/2014CN103751083A Weight-reduction essential oil
04/30/2014CN103751044A Face-thinning firming and lifting mask
04/30/2014CN103750344A Yeast glutathione nutrition preparation
04/30/2014CN103750322A Health-care food for regulating blood fat
04/30/2014CN103750317A Andrias davidianus oil sustained-release dropping pill
04/30/2014CN103750304A Weight-reducing, fat-reducing and health-protection rhizoma alismatis oral liquid and preparation method thereof
04/30/2014CN103750295A Plant polyphenol composition having blood fat reducing function, and preparation method thereof
04/30/2014CN103750107A Health-care product with blood glucose reducing function
04/30/2014CN103749858A Yellow lotus antihypertensive tea
04/30/2014CN103749819A Cornus officinalis sieb health-care tea capable of lowering blood sugar and lowering lipid and preparation method of tea
04/30/2014CN103749771A Dendrobium officinale fat-reducing and blood pressure-lowering tea
04/30/2014CN103193661B Potassium aspartate crystal, and preparation method of potassium magnesium aspartate drug composition
04/30/2014CN103142524B Calcitriol tablet and preparation method thereof
04/30/2014CN103083377B Giant salamander bone calcium tablet and preparation method thereof
04/30/2014CN103041361B Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof
04/30/2014CN102988816B Traditional Chinese medicine slimming oral liquid for treating children simple obesity
04/30/2014CN102872423B Traditional Chinese medicine compound for treating glycuresis and preparation method thereof
04/30/2014CN102744136B Preparation method for nanometre pearl powder and prepared nanometer pearl powder
04/30/2014CN102718870B Insulin bio-sensitizer and application thereof
04/30/2014CN102670643B Medicine for lowering total cholesterol
04/30/2014CN102526075B Fat-soluble vitamin freeze-dried injection and preparation method thereof
04/30/2014CN102423382B Chinese medicine composition for treating dyslipidemia and application thereof
04/30/2014CN102406836B Chinese medicine composition with auxiliary function of lowering blood sugar and preparation method of Chinese medicine composition
04/30/2014CN102307587B Use of APL-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
04/30/2014CN102007123B Heterocyclic inhibitors of stearoyl-CoA desaturase
04/30/2014CN101898962B Rhein crystal B-type solid matter, preparation method and use
04/30/2014CN101896481B Pyrimidyl indoline compound
04/30/2014CN101724075B Remodeling and glycoconjugation of peptides
04/29/2014US8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
04/29/2014US8710074 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators
04/29/2014US8710030 Phosphonate compounds
04/29/2014US8710025 Modified and stabilized GDF propeptides and uses thereof
04/29/2014US8710017 Human and mouse targeting peptides identified by phage display
04/29/2014US8710003 Treatment of diabetes with milk protein hydrolysate
04/29/2014US8710002 Methods of enhancing diabetes resolution
04/29/2014US8710000 Insulin derivative
04/29/2014US8709998 Peptide vectors
04/29/2014US8708994 Method for altering drug pharmacokinetics based on medical delivery platform
04/29/2014CA2693406C Compounds and methods for modulating fxr
04/29/2014CA2651153C Antidiabetic bicyclic compounds
04/29/2014CA2408571C Mammalian receptor proteins; related reagents and methods
04/24/2014WO2014062938A1 Rory modulators
04/24/2014WO2014062794A1 Compositions and methods for improving glucose uptake
04/24/2014WO2014061823A1 Method for treating type i and type ii diabetes
04/24/2014WO2014061821A1 Grb10 interacting gyf protein 2 modulator
04/24/2014WO2014061808A1 Nutritional composition for gastrostomy-tube patients
04/24/2014WO2014061764A1 Xanthene derivative
04/24/2014WO2014061693A1 Novel non-aromatic carbocyclic or non-aromatic heterocyclic derivative
04/24/2014WO2014061647A1 Prenyloxyquinoline carboxylic-acid derivative
04/24/2014WO2014061031A1 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
04/24/2014WO2014060244A1 Process for obtaining caffeoylquinic acids-rich extracts from helianthus annuus
04/24/2014WO2014060112A1 Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
04/24/2014WO2014059928A1 Anticancer and anti-obesity cyclic peptide agents
04/24/2014WO2014059797A1 Use of ivermectin and derivatives thereof
04/24/2014WO2014059702A1 Benfotiamine polymorphs, preparation method and use thereof
04/24/2014WO2014059649A1 Lycopene microcapsule preparation method
04/24/2014WO2014059536A1 Combination of an insulin and tissue kallikrein 1
04/24/2014WO2014059499A1 Preparation method and composition of a pharmaceutical drug from quenodeoxicholate linked to a natural, d-fructose-analogue, sulfamate-derived monosaccharide (topiramate) and to a phenylketone (bupropion) for the treatment of obesity and plurimetabolic syndromes
04/24/2014US20140113969 Preventing And/Or Treating Cardiovascular Disease And/Or Associated Heart Failure
04/23/2014EP2722386A1 Crushed cells and composition thereof
04/23/2014EP2722054A1 Methods and compositions for oral administration of proteins
04/23/2014EP2721065A1 Anti-angptl3 antibodies and uses thereof
04/23/2014EP2721063A1 Pcsk9-binding polypeptides and methods of use
04/23/2014EP2721062A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
04/23/2014EP2721047A2 Methods for the synthesis and purification of deoxycholic acid
04/23/2014EP2721000A1 Synthetic epigallocatechin gallate (egcg) analogs
04/23/2014EP2720718A2 Anti-cd3 therapies
04/23/2014EP2720713A2 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
04/23/2014EP2720703A1 Methods for increasing insulin sensitivity and treating diabetes
04/23/2014EP2720564A1 Flour-based functional food
04/23/2014CN103748109A Glucagon/glp-1 receptor co-agonists
04/23/2014CN103748094A Tricyclic sulfonamide compounds and methods of making and using same
04/23/2014CN103748090A Glycoside derivatives and their uses for the treatment of diabetes
04/23/2014CN103747806A Non-peptidyl polymer-insulin multimer and method for producing same
04/23/2014CN103747781A Liquid pharmaceutical composition comprising nitisinone
04/23/2014CN103740557A Health care wine for preventing diabetes and preparation method thereof
04/23/2014CN103739666A Dipeptide QE with dual functions of lowering blood pressure and lowering blood fat and application thereof
04/23/2014CN103739665A Dipeptide TE with dual functions of lowering blood pressure and lowering blood fat and application thereof
04/23/2014CN103739653A Novel 23-oleanolic acid compound as well as preparation method and application of compound in preparation of glycosidase inhibitor medicine
04/23/2014CN103739652A New 23, 29-drop oleanolic acid compound, preparation method thereof and application in preparation of glucosidase inhibitor medicines
04/23/2014CN103739651A Preparation method of panax japonicus Ib and application of panax japonicus Ib in preparation of inhibitory drug fibrinolytic enzyme original activator inhibitor (PAI-1)
04/23/2014CN103739647A Non-hormonal steroid modulators of nf-kb for treatment of disease
04/23/2014CN103739581A C-aryl glucoside SGLT2 (Sodium-Glucose Co-transporter 2) inhibitor
04/23/2014CN103738980A Method for preparing high-purity water salt and serial products by using well and rock salt raw material brine
04/23/2014CN103736083A Composition for detoxifying, beautifying and slimming
04/23/2014CN103736082A Combination of an insulin and a glp-1 agonist
04/23/2014CN103736077A Dipeptide ES with double functions of lowering blood pressure and lowering blood fat and application thereof
04/23/2014CN103736076A Dipeptide DL with double functions of lowering blood pressure and lowering blood fat and application thereof
04/23/2014CN103736071A Composition having effect of assisting in decreasing blood sugar, and application and preparation method thereof
04/23/2014CN103736052A Chinese medicinal composition for assisting in decreasing blood sugar and preparation method thereof
04/23/2014CN103736011A Injection nursing medicine for lowering cholesterol and preparation method thereof
04/23/2014CN103735940A Traditional Chinese medicinal prescription for promoting squab growth, as well as preparation method and application thereof
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 1298